Postdoctoral Fellow, University of Colorado, Boulder, Colorado
We end the year with the plant genus Cannabis, belonging to the family Cannabaceae, which also includes hops (Humulus sp.) and Hackberries (Celtis). Cannabis is most famous today for its use as a recreational drug, aka marijuana, although the legalization of this plant as a drug has been quite controversial in the United States and across the world. Despite its notoriety, however, the origins, chemical properties, reproductive strategies and dispersal of Cannabis across the globe are quite fascinating and this plant genus has been impacting human culture for ages. Cannabis is one of the oldest domesticated plants and various ancient human cultures have used it for spiritual rituals, medicinal purposes, and fiber for rope or clothing that has been extracted from hemp plants (Li 1973, 1974; Russo, 2007, 2008). The genus most likely originated in Central, South or Eastern Asia but the exact origin of Cannabis is difficult to determine because of shifts in its distribution between glacial cycles (Clarke & Merlin 2013). Humans brought this species to Europe and later to Africa and the Americas where it was cultivated and domesticated into different varieties (Clarke & Merlin 2013).
Carolus Linnaeus, the founder of the binomial species system, was the first person to classify the Cannabis genus in 1753, and only identified a single species, Cannabis sativa L. However, Jean Baptiste Lamarck (yes, the one who came up with a first theory of adaptation, now known and disregarded as “Lamarckian evolution”) described a second species, Cannabis indica, in 1785 (Watts, 2006). While the validity of the second species is debated, the groupings “sativa” and “indica” are still commonly used. Interestingly, Cannabis has an unusual amount of genetic diversity when compared to other plant groups (Sawler et al. 2015; Lynch et al. 2016; Vergara et al. 2016). Recent scientific research has found that there are genetic clusters, and thus it is possible that several other species will be described. However, these do not seem to reflect Lamarck’s classification of C. sativa and C. indica (Sawler et al. 2015; Lynch et al. 2016; Vergara et al. 2016).
What molecular properties and processes make this plant so popular as a recreational drug? Cannabis produces cannabinoids, which interact with our own endocannabinoid system within the brain and nervous system (Gertsch 2008). The endocannabinoid system is involved in regulating multiple physiological processes, including sleep and hunger. One of the primary and most widely known cannabinoids produced by the Cannabis plant is Δ-9-tetrahydrocannabinolic acid (THCA), which is converted to the neutral form Δ-9-tetrahydrocannabinol (THC) once heated. This neutral form interacts with the endocannabinoid system producing a psychoactive effect (gets us “high”). THC also seems to have important medical uses potentially serving as treatment for Parkinson’s disease (Carrol et al. 2012), dementia (Walther et al. 2006), and autoimmune disorders (Lyman et al. 1989). The other well-known cannabinoid in Cannabis is cannabidiolic acid (CBDA), which produces cannabidiol (CBD) when heated. Data suggest CBD, which is not psychoactive, may mitigate some of the negative effects of THC (such as anxiety and paranoia) and has potential uses in treating cancer (Soliman et al. 2015) and epilepsy (Mechoulam et al. 2002; Devinsky et al. 2014). Besides THC and CBD, Cannabis produces around 74 different cannabinoids (ElSohly et al. 2005; Radwan et al. 2008; ), which are present at varying potencies and ratios across particular cultivars and may also have medical importance, including cannabigerol (CBG) Borelli et al., 2014), cannabichrome (CBC) (Izzo et al. 2012) and Δ-9-tetrahydocannabivarin (THCV) (McPartland et al. 2015).
Cannabis also has interesting reproductive strategies. It can be either dioecious, meaning that there are male and female plants, similar to what we see in humans and other animals (Soltis et al. 2005; Bell et al. 2015). However some Cannabis varieties are monoecious, and thus produce both males and female flowers in the same plant. To make this even more confusing, when environmentally stressed, some male plants can produce female flowers and some female plants can produce male flowers. Additionally, sex is determined by two chromosomes, X and Y (thus males are XY and females are XX), but the hermaphrodites have undifferentiated chromosomes (Hirata 1929; Yamado 1943; Sakomoto et al. 1998). Interestingly, males, females and hermaphrodites can cross with each other and produce fertile offspring.
About the Author
Dr. Daniela Vergara is post-doctoral researcher at the University of Colorado, Boulder, where she is working in Dr. Nolan Kane’s lab Cannabis Genomic Research Initiative. Specifically, Daniela has been exploring the cannabinoid genes in the genome and understanding the how these genes relate to the chemotypes. Daniela also founded and is the director of a non-profit organization The Agricultural Genomics Foundation that holds a 501(C)(3) status (AGF; AgriculturalGenomics.org) and aims in becoming a genomic repository (“library of genomes”) helping CGRI perform their research. AGF also educates the public about science, Cannabis, evolutionary biology, and genomics, through public talks.
Bell, C. D., D. E. Soltis & P. S. Soltis. 2010. The age and diversification of the angiosperms re-revisited. American Journal of Botany 97: 1296–1303.
Borrelli, F., E. Pagano, B. Romano, S. Panzera, F. Maiello, D. Coppola, L. De Petrocellis, L. Buono, P. Orlando & A. A. Izzo. 2014. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis 35: bgu205.
Carroll, C. B., M‐L. Zeissler, C. O. Hanemann & J. P. Zajicek. 2012. Δ9‐tetrahydrocannabinol (Δ9‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. Neuropathology and Applied Neurobiology 38: 535–547.
Clarke, R. C. & M. D. Merlin. 2013. Cannabis: evolution and ethnobotany. University of California Press.
Devinsky, O., M. R. Cilio, H. Cross, J. Fernandez‐Ruiz, J. French, C. Hill, R. Katz, V. Di Marzo, D. Jutras‐Aswad, W. G. Notcutt & J. Martinez‐Orgado. 2014. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55: 791–802.
ElSohly, M.A. & D. Slade. 2005. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life sciences 78: 539–548.
Gertsch, J., M. Leonti, S. Raduner, I. Racz, J.-Z. Chen, X.-Q. Xie, K.-H. Altmann, M. Karsak & A. Zimmer. 2008. Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences 105: 9099–9104.
Hirata, K. 1929: Cytological basis of the sex determination in Cannabis sativa. Idengaku Zasshi. 4: 198–201.
Izzo, A. A., R. Capasso, G. Aviello, F. Borrelli, B. Romano, F. Piscitelli, L. Gallo, F. Capasso, P. Orlando & V. Di Marzo. 2012. Inhibitory effect of cannabichromene, a major non‐psychotropic cannabinoid extracted from Cannabis sativa, on inflammation‐induced hypermotility in mice. British journal of Pharmacology 166: 1444–1460.
Li, H. L. 1973. An archaeological and historical account of cannabis in China. Economic Botany 28: 437–448.
Li, H. L. 1974. Origin and use of Cannabis in Eastern Asia; Linguistic-cultural implications. Economic Botany 28: 293–301.
Lyman, W. D., J. R. Sonett, C. F. Brosnan, R. Elkin & M. B. Bornstein. 1989. Δ 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. Journal of neuroimmunology 23: 73–81.
Lynch, R. C., D. Vergara, S. Tittes, K. White, C. J. Schwartz, M. J. Gibbs, T. C. Ruthenburg, K. deCesare, D. P. Land & N. C. Kane. 2016. Genomic and Chemical Diversity in Cannabis. Critical Reviews in Plant Sciences 35: 349–363.
McPartland, J. M., M. Duncan, V. Di Marzo & R. G. Pertwee. 2015. Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. British journal of pharmacology 172: 737–753.
Mechoulam, R., L.A. Parker & R. Gallily. 2002. Cannabidiol: an overview of some pharmacological aspects. The Journal of Clinical Pharmacology 42: 11S-19S.
Radwan, M. M., S. A. Ross, D. Slade, S. A. Ahmed, F. Zulfiqar & M. A. ElSohly. 2008. Isolation and characterization of new Cannabis constituents from a high potency variety. Planta medica 74: 267–272.
Russo, E. B. 2007. History of Cannabis and its preparations in saga, science, and sobriquet. Chemistry & Biodiversity 4: 1614–1648.
Russo, E. B., H. E. Jiang, X. Li, A. Sutton, A. Carboni, F. Del Bianco, G. Mandolino, D. J. Potter, Y. X. Zhao, S. Bera & Y. B. Zhang. 2008. Phytochemical and genetic analyses of ancient cannabis from Central Asia. Journal of Experimental Botany 59: 4171–4182.
Sakamoto, K., Y. Akiyama, K. Fukui, H. Kamada & S. Satoh 1998. Characterization; Genome Sizes and Morphology of Sex Chromosomes in Hemp (Cannabis sativa L.). Cytologia 63: 459–464.
Sawler, J., J. M. Stout, K. M. Gardner, D. Hudson, J. Vidmar, L. Butler, J. E. Page & S. Myles. 2015. The Genetic Structure of Marijuana and Hemp. PloS One 10: e0133292.
Solinas, M., V. Cinquina & D. Parolaro. 2015. Cannabidiol and Cancer—An Overview of the Preclinical Data. In Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor. InTech.
Soltis, D. E., P. S. Soltis, P. K. Endress & M. W. Chase. 2005. Phylogeny and evolution of angiosperms. Sinauer Associates Incorporated.
Walther, S., R. Mahlberg, U. Eichmann & D. Kunz. 2006. Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology 185: 524–528.
Watts, G. 2006. Science commentary: Cannabis confusions. BMJ: British Medical Journal 332: 175.
Vergara, D., H. Baker, K. Clancy, K. G. Keepers, J. P. Mendieta, C. S. Pauli, S. B. Tittes, K. H. White & N. C. Kane. 2016. Genetic and Genomic Tools for Cannabis sativa. Critical Reviews in Plant Sciences 35: 364–377.
Yamada, I. 1943. The sex chromosome of Cannabis sativa L. Seiken Ziho. 2: 64–68.